Imaging of large volume subcutaneous deposition using MRI: exploratory clinical study results.

Autor: Pettis RJ; BD Technologies & Innovation, 21 Davis Dr., Research Triangle Park, Durham, NC, 27709, USA. rpettis@bd.com., Woodley WD; BD Technologies & Innovation, 21 Davis Dr., Research Triangle Park, Durham, NC, 27709, USA., Ossege KC; Kinetic Vision, 10651 Aerohub Blvd., Cincinnati, OH, 45215, USA., Blum A; Kinetic Vision, 10651 Aerohub Blvd., Cincinnati, OH, 45215, USA., Bolick NG; BD Technologies & Innovation, 21 Davis Dr., Research Triangle Park, Durham, NC, 27709, USA., Rini CJ; BD Technologies & Innovation, 21 Davis Dr., Research Triangle Park, Durham, NC, 27709, USA.
Jazyk: angličtina
Zdroj: Drug delivery and translational research [Drug Deliv Transl Res] 2023 Sep; Vol. 13 (9), pp. 2353-2366. Date of Electronic Publication: 2023 Mar 13.
DOI: 10.1007/s13346-023-01318-7
Abstrakt: Subcutaneous (SC) delivery is a preferred route of administration for biotherapeutics but has predominantly been limited to volumes below 3 mL. With higher volume drug formulations emerging, understanding large volume SC (LVSC) depot localization, dispersion, and impact on the SC environment has become more critical. The aim of this exploratory clinical imaging study was to assess the feasibility of magnetic resonance imaging (MRI) to identify and characterize LVSC injections and their effect on SC tissue as a function of delivery site and volume. Healthy adult subjects received incremental injections of normal saline up to 5 mL total volume in the arm and up to 10 mL in the abdomen and thigh. MRI images were acquired after each incremental SC injection. Post-image analysis was performed to correct imaging artifacts, identify depot tissue location, create 3-dimensional (3D) SC depot rendering, and estimate in vivo bolus volumes and SC tissue distention. LVSC saline depots were readily achieved, imaged using MRI, and quantified via subsequent image reconstructions. Imaging artifacts occurred under some conditions, necessitating corrections applied during image analysis. 3D renderings were created for both the depot alone and in relation to the SC tissue boundaries. LVSC depots remained predominantly within the SC tissue and expanded with increasing injection volume. Depot geometry varied across injection sites and localized physiological structure changes were observed to accommodate LVSC injection volumes. MRI is an effective means to clinically visualize LVSC depots and SC architecture allowing assessment of deposition and dispersion of injected formulations.Trial Registration: Not applicable for this exploratory clinical imaging study.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: